Hesperos

Hesperos is a privately held, US-based biotech firm founded in 2015, specializing in advanced organ-on-a-chip systems. Its core technology involves interconnected, reconfigurable platforms that simulate the functional aspects of human organs, aiming to reduce animal testing and improve the predictability of drug development. The company operates a service-based business model, offering custom disease modeling and drug testing assays to research institutes and pharmaceutical partners. Hesperos is positioned as a leader in this niche field, leveraging strong academic foundations and intellectual property.

Patented Human-on-a-Chip® systems: interconnected, reconfigurable, pumpless (gravity-flow) microfluidic platforms that use human cells to create functional, multi-organ in vitro models for disease modeling and drug testing.

Hesperos competes in the organ-on-a-chip market against companies like Emulate, Mimetas, and TissUse, as well as numerous academic spin-offs. Its primary differentiators are its focus on functional, electrophysiological readouts, its patented pumpless gravity-flow system, and its strong heritage in the foundational science of multi-organ systems.